These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26783358)

  • 1. Impact of Combination Antibiogram and Related Education on Inpatient Fluoroquinolone Prescribing Patterns for Patients With Health Care-Associated Pneumonia.
    Liang B; Wheeler JS; Blanchette LM
    Ann Pharmacother; 2016 Mar; 50(3):172-9. PubMed ID: 26783358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
    Paladino JA; Sunderlin JL; Forrest A; Schentag JJ
    J Antimicrob Chemother; 2003 Sep; 52(3):457-63. PubMed ID: 12888598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of an empiric antibiotic regimen for hospital-acquired pneumonia using a unit and culture-type specific antibiogram.
    Green DL
    J Intensive Care Med; 2005; 20(5):296-301. PubMed ID: 16145220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
    Vaughn VM; Gandhi T; Conlon A; Chopra V; Malani AN; Flanders SA
    Clin Infect Dis; 2019 Sep; 69(8):1269-1277. PubMed ID: 30759198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia.
    Pogue JM; Alaniz C; Carver PL; Pleva M; Newton D; DePestel DD
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):289-92. PubMed ID: 21460516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
    Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
    Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia.
    Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H
    J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study.
    Chalmers JD; Taylor JK; Singanayagam A; Fleming GB; Akram AR; Mandal P; Choudhury G; Hill AT
    Clin Infect Dis; 2011 Jul; 53(2):107-13. PubMed ID: 21690616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a urinary-specific antibiogram for gram-negative isolates: impact of patient risk factors on susceptibility.
    Rabs N; Wieczorkiewicz SM; Costello M; Zamfirova I
    Am J Infect Control; 2014 Apr; 42(4):393-400. PubMed ID: 24559594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram.
    Mizuta M; Linkin DR; Nachamkin I; Fishman NO; Weiner MG; Sheridan A; Lautenbach E
    Infect Control Hosp Epidemiol; 2006 Apr; 27(4):413-5. PubMed ID: 16622822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.
    Hsu DI; Okamoto MP; Murthy R; Wong-Beringer A
    J Antimicrob Chemother; 2005 Apr; 55(4):535-41. PubMed ID: 15728150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpatient Fluoroquinolone Stewardship Improves the Quantity and Quality of Fluoroquinolone Prescribing at Hospital Discharge: A Retrospective Analysis Among 122 Veterans Health Administration Hospitals.
    Suzuki H; Perencevich EN; Alexander B; Beck BF; Goto M; Lund BC; Nair R; Livorsi DJ
    Clin Infect Dis; 2020 Aug; 71(5):1232-1239. PubMed ID: 31562815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the fluoroquinolone combination necessary for empirical antibiotic regimen in severe community-acquired pneumonia?
    Oh S; Jang W; Kim B
    Postgrad Med; 2024 Apr; 136(3):337-345. PubMed ID: 38658366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients.
    Park SC; Kim EY; Kang YA; Park MS; Kim YS; Kim SK; Chang J; Jung JY
    Int J Tuberc Lung Dis; 2013 May; 17(5):704-9. PubMed ID: 23575340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.